| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |